Sunday, June 23, 2013
Hyatt Regency Chicago • 151 E. Wacker Dr.
Grand Ballroom A-D North
- 6:30 pm – 7:00 pm
- Registration & Dinner
- 7:00 pm – 9:00 pm
- CME-Certified Symposium
- Pre-registration recommended but not required.
Seating to be based on arrival order; early arrival is recommended.
Obesity has increased dramatically in the past 20 years, and is considered a healthcare epidemic in the United States. One-third of adults in the United States are considered obese, having a body mass index (BMI) ≥ 30 kg/m2, according to the US Centers for Disease Control and Prevention. Serious health concerns associated with obesity include increased risk for hypertension, stroke, coronary heart disease, dyslipidemia, type 2 diabetes (T2DM), depression, sleep apnea, osteoarthritis, infertility, as well as cancers of the colon, breast, and endometrium. A BMI of ≥ 35 kg/m2, increased waist circumference, and waist-to-hip ratio are predictors of increased risk for mortality. Particular challenges exist in the management of the obese patient with T2DM. Staying current with evidence-based recommendations for treatment, including knowledge of the safety and efficacy of emerging therapeutic options, is vital to healthcare practitioners as they work with patients to develop optimal, individualized, long-term strategies for overcoming obesity. This CME program will feature an interactive, audience driven case-based approach to address the association between obesity and T2DM, overcoming barriers to determine the appropriate strategy for managing overweight patients with diabetes, and safety, efficacy, and the appropriate use of newly approved medications to treat obesity.